Literature DB >> 17804882

Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study.

Y Lin1, H Gao, O Nalcioglu, G Gulsen.   

Abstract

Fluorescence diffuse optical tomography (FT) is an emerging molecular imaging technique that can spatially resolve both fluorophore concentration and lifetime parameters. In this study, we investigate the performance of a frequency-domain FT system for small inclusions that are embedded in a heterogeneous background. The results demonstrate that functional and structural a priori information is crucial to be able to recover both parameters with high accuracy. The functional a priori information is defined by the absorption and scattering maps at both excitation and emission wavelengths. Similarly, the boundaries of the small inclusion and different regions in the background are utilized as the structural a priori information. Without a priori information, the fluorophore concentration of a 5 mm inclusion in a 40 mm medium is recovered with 50% error, while the lifetime cannot be recovered at all. On the other hand, when both functional and structural information are available, the true lifetime can be recovered and the fluorophore concentration can be estimated only with 5% error. This study shows that a hybrid system that can acquire diffuse optical absorption tomography (DOT), FT and anatomical images in the same setting is essential to be able to recover the fluorophore concentration and lifetime accurately in vivo.

Mesh:

Year:  2007        PMID: 17804882     DOI: 10.1088/0031-9155/52/18/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  26 in total

Review 1.  Going deeper than microscopy: the optical imaging frontier in biology.

Authors:  Vasilis Ntziachristos
Journal:  Nat Methods       Date:  2010-07-30       Impact factor: 28.547

2.  Quantitative fluorescence tomography using a trimodality system: in vivo validation.

Authors:  Yuting Lin; William C Barber; Jan S Iwanczyk; Werner W Roeck; Orhan Nalcioglu; Gultekin Gulsen
Journal:  J Biomed Opt       Date:  2010 Jul-Aug       Impact factor: 3.170

Review 3.  Using in-vivo fluorescence imaging in personalized cancer diagnostics and therapy, an image and treat paradigm.

Authors:  Y Ardeshirpour; V Chernomordik; J Capala; M Hassan; R Zielinsky; G Griffiths; S Achilefu; P Smith; A Gandjbakhche
Journal:  Technol Cancer Res Treat       Date:  2011-12

4.  A photo-multiplier tube-based hybrid MRI and frequency domain fluorescence tomography system for small animal imaging.

Authors:  Y Lin; M T Ghijsen; H Gao; N Liu; O Nalcioglu; G Gulsen
Journal:  Phys Med Biol       Date:  2011-07-13       Impact factor: 3.609

5.  Artifact reduction method in ultrasound-guided diffuse optical tomography using exogenous contrast agents.

Authors:  Yasaman Ardeshirpour; Nrusingh Biswal; Andres Aguirre; Quing Zhu
Journal:  J Biomed Opt       Date:  2011-04       Impact factor: 3.170

6.  Fluorescence imaging of vascular endothelial growth factor in tumors for mice embedded in a turbid medium.

Authors:  Nrusingh C Biswal; John K Gamelin; Baohong Yuan; Marina V Backer; Joseph M Backer; Quing Zhu
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

7.  A True Multi-modality Approach for High Resolution Optical Imaging: Photo-Magnetic Imaging.

Authors:  Alex T Luk; Seunghoon Ha; Farouk Nouizi; David Thayer; Yuting Lin; Gultekin Gulsen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-02-19

8.  In vivo validation of quantitative frequency domain fluorescence tomography.

Authors:  Yuting Lin; Michael Ghijsen; Orhan Nalcioglu; Gultekin Gulsen
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

9.  Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore.

Authors:  W C Barber; Y Lin; O Nalcioglu; J S Iwanczyk; N E Hartsough; G Gulsen
Journal:  Technol Cancer Res Treat       Date:  2010-02

10.  Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system.

Authors:  Yuting Lin; William C Barber; Jan S Iwanczyk; Werner Roeck; Orhan Nalcioglu; Gultekin Gulsen
Journal:  Opt Express       Date:  2010-04-12       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.